Literature DB >> 4364158

Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning.

Y Suzuki, K Hisada, M Takeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4364158     DOI： 10.1148/111.3.663

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  8 in total

1.  99mTc-methylene diphosphonate and 67Ga-uptake in myositis ossificans.

Authors:  C J Edeling
Journal:  Eur J Nucl Med       Date:  1986

2.  Case report 488: Post-traumatic myositis ossificans mimicking a soft tissue neoplasm.

Authors:  L Ackerman; S Ramamurthy; V Jablokow; M Van Drunen; E Kaplan
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

3.  Quantitative assessment of 99mTc-MDP scans in investigation of diffuse alterations in bone.

Authors:  J P Pfeifer; U Büll; H Pfeifer
Journal:  Eur J Nucl Med       Date:  1979-12

4.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

5.  Bone scintigraphy of myositis ossificans in apallic syndrome.

Authors:  Z Szabó; F Ritzl; S Chittima; G A Laszlo; C Neumann
Journal:  Eur J Nucl Med       Date:  1982

6.  Accumulation of 99mTc-pyrophosphate in a muscle hernia of the thigh.

Authors:  C Shigeno; M Fukunaga; I Yamamoto; R Morita; M Hino; K Torizuka; Y Kodama; T Kawashima
Journal:  Eur J Nucl Med       Date:  1981

7.  Studies on the Labeling of Ethylenediaminetetramethylene Phosphonic Acid, Methylene Diphosphonate, Sodium Pyrophosphate and Hydroxyapatite with Lutetium-177 for use in Nuclear Medicine.

Authors:  Imtiaz Ahmed Abbasi
Journal:  World J Nucl Med       Date:  2015 May-Aug

Review 8.  Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment.

Authors:  Paweł Łęgosz; Maciej Otworowski; Aleksandra Sibilska; Krzysztof Starszak; Daniel Kotrych; Adam Kwapisz; Marek Synder
Journal:  Biomed Res Int       Date:  2019-04-16       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.